Finance

Lists
Q3 2026 earnings • released • EPS beat +283.98%
See results
EWTX:NASDAQ
Edgewise Therapeutics Inc
$44.88
+15.47%
(+6.01) 1D
Nov 6, 2:49:42 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EWTX...
Open
$39.71
High
$45.23
Low
$38.04
Mkt. cap
4.87B
Avg. vol.
1.62M
Volume
2.25M
P/E ratio
5.48
52-wk high
$48.50
52-wk low
$16.70
EPS
$8.18
Beta
0.39
Shares outstanding
109.48M
No. of employees
127
Open
$39.71
High
$45.23
Low
$38.04
Mkt. cap
4.87B
Avg. vol.
1.62M
Volume
2.25M
P/E ratio
5.48
52-wk high
$48.50
52-wk low
$16.70
EPS
$8.18
Beta
0.39
Shares outstanding
109.48M
No. of employees
127
News stories
From web sources and news partners
About Edgewise Therapeutics Inc
CEO-
Employees127
Founded2017
HeadquartersBoulder, Colorado, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteedgewisetx.com
Analyst ratings
Based on 12 analysts giving stock ratings to EWTX in the past 3 months
Strong buy
Buy
10
Hold
2
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for EWTX in the last 3 months.
Highest
Current $44.88
$85.00 (+89.37%)
Average
$54.30 (+20.98%)
Lowest
$36.00 (-19.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$51.00
+13.6%
11/06/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$55.00
+22.5%
11/05/2026
Martin Auster
Raymond James
Buy
Reiterated
$85.00
+89.4%
11/05/2026
James Condulis
Stifel Nicolaus
Hold
Reiterated
$36.00
-19.8%
11/05/2026
Laura Chico
Wedbush
Buy
Maintained
$51.00
+13.6%
11/06/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
$59.00
+31.4%
11/05/2026
Lander Egana Gorrono
H.C. Wainwright
Buy
Maintained
$57.00
+27%
11/05/2026
Unknown Analyst
William Blair
Buy
Initiated
$53.00
+18.1%
10/15/2026
Sharon Zackfia
William Blair
Buy
Initiated
$53.00
+18.1%
10/15/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
-
-
09/23/2026
Paul Choi
Goldman Sachs
Hold
Maintained
$36.00
-19.8%
09/22/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
-
-
09/23/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
$60.00
+33.7%
08/20/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$45.00
+0.3%
08/06/2026
Mazahir Alimohamed
Oppenheimer
Buy
Initiated
$51.00
+13.6%
07/09/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
$51.00
+13.6%
07/06/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$41.00
-8.7%
06/02/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
$20.00
-55.4%
05/11/2026
David Nierengarten
Wedbush
Buy
Maintained
$46.00
+2.5%
05/08/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$9.65 / $2.51
+283.98%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-1.35B
Cost of revenue
-
-
-
-1.35B
Research and development expenses
43.59M
42.65M
47.55M
31.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.38M
11.46M
14.40M
14.57M
Operating expense
55.98M
54.12M
61.94M
46.14M
Total operating expenses
55.98M
54.12M
61.94M
-1.30B
Operating income
-55.98M
-54.12M
-61.94M
1.30B
Other non operating income
-
-
-
3.06M
EBT including unusual items
-50.22M
-49.01M
-57.33M
1.32B
EBT excluding unusual items
-50.22M
-49.01M
-57.33M
1.32B
Income tax expense
-
-
-
155.33M
Effective tax rate
-
-
-
11.75%
Other operating expenses
-
-
-
-
Net income
-50.22M
-49.01M
-57.33M
1.17B
Net profit margin
-
-
-
-
Earnings per share
-0.47
-0.46
-0.53
9.65
Interest and investment income
5.76M
5.10M
4.62M
16.50M
Interest expense
-
-
-
-
Net interest expenses
5.76M
5.10M
4.62M
16.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-55.45M
-53.58M
-61.40M
1.30B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps